Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Injections improve hair growth, density, and thickness in women safely.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.